The Belgian Hematology Society (BHS), with the support of an unrestricted grant from Sanofi, has the pleasure to announce the “SAFYHR Award”.
PROJECT SUBMISSION IS CLOSED!
Consult the SAFYHR Award flyer
Young hematologists or hematologists in training are invited to submit their project and apply for the Sanofi Award for Young Hematologist Research.
The “SAFYHR Award” jury will select only “one” innovating project which will be awarded with 15.000 euro.
The award ceremony will take place at the 39th BHS general annual meeting on February 2-3, 2024. Discover the past SAFYHR AWARD winners down below!
Sincerely,
Prof. Marc André, President of the BHS
PARTICIPATION REQUIREMENTS "SAFYHR AWARD" 2024
Who can apply?
- Young hematologists in training who are MD and are within 10 years after MD graduation.
Important note: Candidates working at a pharmaceutical company are excluded.
Which projects are eligible?
- The topic of research is related to transnational research within the field of hematology.
Application requirements?
- Description of the research project including costs and timeframe (max. 2 pages) - Example project submission SAFYHR award 2024.docx
- Letter of support by a promotor from the department where the research will be performed (max. 1 page)
- Motivational letter (max. 1 page)
- List of publications (if applicable)
- CV
Only submission through the online tool is possible. Submissions sent by e-mail will not be considered.
SAFYHR Award
A prize award will be given to the winner. Please note, the prize money cannot be allocated to fund a salary. The results of the selection will be announced during the 2024 General Annual Meeting of the BHS. The SAFYHR Award has been made possible with an unrestricted grant from Sanofi.
Past Winners
2023
| Winner | Project |
| Quentin Van Thillo, KU Leuven | Targeting NOTCH1/2-positive diffuse large B-cell lymphoma (DLBCL) with presenilin 1-selective gamma-secretase inhibitors |
2022
| Winner | Project |
|
Philippe Decruyenaere, Ghent University Hospital
|
Nucleic acid profiling in diffuse large B-cell lymphoma: a molecular guidance to precision medicine |
2021
| Winner | Project |
|
The development of advanced humanized patient-derived tumor xenograft models of lymphoproliferative malignancies for the evaluation of novel therapeutics |